Barrington raised the firm’s price target on ModivCare to $143 from $138 and keeps an Outperform rating on the shares, saying the company delivered "solid" Q4 results. The firm notes that it attributes $3 per share in value for the Matrix investment and assumes roughly $925M in net debt 12 months from now.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on MODV:
